For health professionals
Connect with meaningful, evidence-based information, resources and data insights to inform your practice.
Rheumatoid arthritis affects around 2% of Australians, and has major effects on quality of life. Find out more about its diagnosis and management.
Like warfarin, non-vitamin K antagonist oral anticoagulants (NOACs) are no longer ‘new’. Knowing similarities and differences between anticoagulants is key to their safe and effective use.
Knee and hip osteoarthritis
This program offers practical tools and strategies to improve quality of life for patients with osteoarthritis
Over-the-counter codeine: changes to supply
Codeine is only available on prescription in Australia from 1 February 2018. Find out more about how health professionals and consumers can manage pain without over-the-counter codeine.
This program reinforces the role of absolute cardiovascular risk assessment and provides tools and resources to address suspected statin-associated muscle symptoms.
Reducing antibiotic resistance
Antibiotic resistance is an urgent global health issue. This program aims to reduce the inappropriate use of antibiotics in the community.
Chronic obstructive pulmonary disease (COPD)
In 2013, COPD was the fifth leading cause of death in Australia. This program reviews the role of spirometry in diagnosis, and the stepwise management of COPD.
Acute ankle and knee injuries
Ankle and knee sprains can be accurately diagnosed without imaging in most cases. This program reviews diagnosis and management of these injuries.
Type 2 diabetes: what's next after metformin?
Diabetes is progressive and patients eventually need more than one medicine to maintain blood glucose control. This program reviews the evidence on sulfonylureas and other agents.
Depression: re-examining the management options
Depression is a common problem in primary care. This program reviews a range of approaches to the management of depression.
High BP is the most frequently managed problem in Australian general practice. This program examined its management as a factor in absolute cardiovascular risk.
Osteoporosis is under-recognised and undertreated in Australia. This program examines targeted investigation and treatment.